Arunaya Organics Regulatory Approval

Board Meeting Date

Arunaya Organics Board Meeting Date

Arunaya Organics will hold a board meeting on 30 October 2026 to consider unaudited standalone half-yearly results for September 2026. Trading window closes from 1 October 2026 until 2 November 2026.

Other Announcement

Arunaya Organics Other Announcement

Arunaya Organics Limited submitted the Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, as required by SEBI regulations.

Annual General Meeting

Arunaya Organics Annual General Meeting

Arunaya Organics Limited held its 16th Annual General Meeting on September 29, 2026, where shareholders transacted the business set out in the meeting notice.

Other Announcement

Arunaya Organics Other Announcement

Arunaya Organics Limited has appointed M/s. Agarwal Roshan & Co. as the Internal Auditor for the financial year 2026-27, in compliance with regulatory requirements.

Board Meeting Outcome

Arunaya Organics Board Meeting Outcome

Arunaya Organics Limited appointed M/s. Agarwal Roshan & Co. as the company's Internal Auditor for the financial year 2026-27.

Annual General Meeting

Arunaya Organics Annual General Meeting

Arunaya Organics Limited scheduled its 16th Annual General Meeting for September 29, 2026, with a record date of September 22, 2026, for voting rights.

Regulatory ApprovalRNFI Services Ltd RNFIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

RNFI Services Regulatory Approval

RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr